Lifeboat Foundation

Efforts to study the early stages of the coronavirus pandemic have received help from a surprising source. A biologist in the United States has ‘excavated’ partial SARS-CoV-2 genome sequences from the beginnings of the pandemic’s probable epicentre in Wuhan, China, that were deposited — but later removed — from a US government database.

The partial genome sequences address an evolutionary conundrum about the early genetic diversity of the coronavirus SARS-CoV-2, although scientists emphasize that they do not shed light on its origins. Nor is it fully clear why researchers at Wuhan University asked for the sequences to be removed from the Sequence Read Archive (SRA), a repository for raw sequencing data maintained by the National Center for Biotechnology Information (NCBI), part of the US National Institutes of Health (NIH).

Partial SARS-CoV-2 sequences from early outbreaks in Wuhan were removed from a US government database by the scientists who deposited them.

Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19.

In a news release, the company said 7.3% of 385 patients who received the antiviral were either hospitalized or died from Covid-19, compared with 14.1% of the 377 patients who received a placebo, which does nothing.

Full data from the molnupiravir trial has not yet been released, and this data has not yet been peer-reviewed or published. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19.

Designing a society that can adapt to the rise of artificial intelligence and allow everyone to thrive as these changes unfold is likely to be one of our most significant challenges in the coming years and decades. It will require an emphasis on retraining and education for those workers who can realistically undertake the necessary transition, as well as an improved safety net – and perhaps an entirely new social contract – for those who will inevitably be left behind.

From fast food to farming, Covid-19 has accelerated the rise of the worker robots. This in turn will put more jobs at risk and makes the need to reframe society ever more urgent.

The computer program used for capturing in vitro RGEN cleavage sites in sequenced genomes is available at.

Contact Seller

Message.

In the spring, a team of University of Virginia and Virginia Tech scientists shared some exciting news: The vaccine they are developing showed promising results in early animal trials not only for COVID-19, but for other coronaviruses.

If that trend continues through further testing, this vaccine could help contain both current and future variants of the COVID-19 virus — including the Delta variant currently plaguing the United States, and other variants that might crop up in the coming months and years. It could even protect against other coronaviruses, including viruses that cause the common cold. And, it could cost as little as $1 a dose.

What if we had a vaccine that would work for any COVID-19 variants that might pop up – and even for some coronaviruses that cause the common cold? UVA and Virginia Tech scientists are working on it.

Stimulating STEM Innovation & Securing U.S. High-Tech Economy — Kimberly A. Reed, Fmr President and Chairman Export-Import Bank of the United States.

Kimberly A. Reed just finished up a 2-year term as President and Chairman of the Board of Directors of the Export-Import Bank of the United States (EXIM — https://www.exim.gov). She was the first woman to lead EXIM in the agency’s 87-year history, was the first recipient of EXIM’s highest honor, the Franklin D. Roosevelt Award, and was confirmed by the U.S. Senate in 2019 on a strong bi-partisan basis.

Continue reading “Kimberly A Reed — Fmr EXIM Chairman / President — Stimulating STEM & Securing U.S. High-Tech Economy” »

#Israel is on the verge of finalizing a #COVID19 vaccine whose creators believe could offer better protection against variants than its international counterparts such as #Pfizer. In an interview with ‘The Jerusalem Post’, the father of Israel’s BriLife coronavirus vaccine, Prof. Shmuel Shapira, predicted that when the country’s #vaccine is ready, “it will be better” than what its citizens have today.

HEALTH AFFAIRS: The father of the BriLife initiative explains Israel’s strategic imperative to have its own vaccine.

Indeed, as Gizmodo’s report highlights, many experts believe that these researchers have not actually found evidence of dinosaur DNA. They told the news outlet, for example, that—even under the best circumstances—DNA couldn’t last more than three million years. Let alone more than 100 million. And that the chemicals may have been staining inorganic matter that only looks cellular in nature.

As of now, the most ancient DNA that scientists have been able to sequence was that of a million-year-old woolly mammoth. And the youngest dinosaurs are at least 65 million years old. But if future experiments do confirm this evidence as real, then that really changes things. At least in our fantasies, where reanimated dinosaurs and Ian Malcolms abound.

The post Fossil of Peacock-Like Dinosaur May Have Preserved DNA Remnants appeared first on Nerdist.

Residents of Abusir el-Meleq, an ancient Egyptian city south of Cairo, the men died between 1,380 B.C.E. and 450 C.E. A team from Parabon NanoLabs presented the trio’s facial reconstructions at the International Symposium on Human Identification in September.

“[T]his is the first time comprehensive DNA phenotyping has been performed on human DNA of this age,” says Parabon, a Virginia-based company that typically uses genetic analysis to help solve cold cases, in a statement.

To approximate the men’s faces, researchers used DNA phenotyping, which predicts individuals’ physical appearance based on genetic markers. (Phenotyping can suggest subjects’ skin, hair and eye color, but as Caitlin Curtis and James Hereward wrote for the Conversation in 2,018 the process has its limitations.) The team determined the mummies’ other characteristics through examination of their physical remains, reports Hannah Sparks for the New York Post.